Lv51
1250 积分 2024-09-01 加入
Generation of Allogeneic CAR T Cells through Specific Degradation of the T Cell Antigen Receptor by E3 Ubiquitin Ligase Fusion Proteins
2天前
已完结
Ultralow-Dose Interleukin 10–Expressing Chimeric Antigen Receptor T Cells in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2天前
已完结
Non-Armored GCC-targeting CAR-T cell therapy demonstrates significant efficacy in patients with advanced colorectal cancer
3天前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
3天前
已完结
Structure and evolution-guided design of minimal RNA-guided nucleases
26天前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
28天前
已完结
A guide to CAR T cell therapies: development, current status and future prospects
1个月前
已完结
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
1个月前
已完结
De novo design of GPCR exoframe modulators
2个月前
已完结
皖公网安备34019202002308
